# Royalty Pharma: portfolio, investments and team

> Royalty Pharma is a growth equity based in United States. 3 investments on record, 1 in the last 12 months, latest Aug 2026.

Source: https://millionrounds.com/fund/royalty-pharma (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Royalty Pharma

Last cheque observed Aug 2026; 3 cheques on record.

Email

Growth equity Deploying now

Series B

Follow Royalty Pharma and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Froyalty-pharma)

Deploying now

**50%** of best year **1** **cheques in 12 months**, 3 on record

Since the last cheque **85** days **00** hrs **00** min **00** sec

Median round **$270M** Rounds led **1 of 3** Sole investor **1 rounds**

Pitch Royalty Pharma

## Royalty Pharma highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series B: 100% of its rounds
- 03 Sole investor in 1 rounds, median $100M

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Based in:** NEW YORK, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **3 appearances**

- **2026** 1 round
- **Aug** **[Zealand Pharma](https://millionrounds.com/company/zealand-pharma)** DK · Firms' own news pages **$100M** *Led*
- **2025** 1 round
- **Oct** **[Kailera Therapeutics](https://millionrounds.com/company/kailera-therapeutics)** Series B · US · Crunchbase News **$600M** With 9 others
- **2019** 1 round
- **Nov** **[Epizyme](https://millionrounds.com/company/epizyme)** US · FinSMEs **$270M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$40B** assets it manages, 3 advisers combined Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** Royalty Pharma Manager, LLC
- **SEC number:** CRD 334982

## The cheque

Series B

Median round joined **$270M** the round, not its cheque Alone, median **$100M**

Led 1 of 3 rounds **33%**

- **Sole investor:** 1 rounds
- **Last cheque:** Aug 2026

Rounds by stage said on their site

- Series B *1*

Cheques by month Led Joined

Dec 2023 Nov 2026

**Pitching Royalty Pharma?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Recently backed

The latest companies Royalty Pharma put money into.

[**Zealand Pharma** $100M · Aug 2026](https://millionrounds.com/company/zealand-pharma)[**Kailera Therapeutics** $600M · Oct 2025](https://millionrounds.com/company/kailera-therapeutics)[**Epizyme** $270M · Nov 2019](https://millionrounds.com/company/epizyme)

## Quick answers about Royalty Pharma

### What does Royalty Pharma invest in?

Royalty Pharma invests most often at Series B (100% of the rounds on record).

### How active is Royalty Pharma?

3 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Aug 2026.

### What has Royalty Pharma invested in recently?

Its most recent investments on record: Zealand Pharma (Undisclosed round, Aug 2026), Kailera Therapeutics (Series B, Oct 2025) and Epizyme (Undisclosed round, Nov 2019).

### How big are Royalty Pharma's cheques?

The median round it joins is $270M.

### Is Royalty Pharma investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### What kind of investor is Royalty Pharma?

Royalty Pharma is a growth equity firm based in NEW YORK, United States.

### How much does Royalty Pharma manage?

About $40B, as regulatory assets under management, 3 advisers added together (Oct 2026).

### When was Royalty Pharma founded?

Royalty Pharma was founded in 1996.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=royalty-pharma) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=royalty-pharma)